ElevateBio raises funds to advance cell and gene therapies
MAY 25, 2023
ElevateBio has raised $401m in a Series D financing round for advancing its technology platforms to expedite the design, production and development of cell and gene therapies. Life Edit will receive an upfront cash payment and $335m in potential development, regulatory and commercial milestones for each of the first two programmes.
Let's personalize your content